Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Tubular aggregate myopathy is a disorder that affects the skeletal muscles. Signs and symptoms typically begin in childhood and worsen over time. The leg muscles are most often affected, but the arm muscles may also be involved. Symptoms include muscle pain, cramping, weakness or stiffness; and exercise-induced muscle fatigue. Affected individuals may have an unusual walking style (gait) or difficulty running, climbing stairs, or getting up from a squatting position. Some individuals develop contractures. This condition may be caused by mutations in the STIM1 or ORAI1 genes. It is usually inherited in an autosomal dominant manner, but autosomal recessive inheritance has also been reported.
Biomarker and diagnostic research for tubular aggregate myopathy has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for tubular aggregate myopathy.
88 publications have been identified in PubMed for tubular aggregate myopathy. Research spans Basic Science / Preclinical (49%), Case Report / Case Series (19%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 43 | 49% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
17 |
19% |
Disease patterns and progression | 10 | 11% |
Research summaries | 8 | 9% |
New treatment approaches | 5 | 6% |
Other research | 2 | 2% |
Clinical study results | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Zhao N (2026). [PMID: 41898235](https://pubmed.ncbi.nlm.nih.gov/41898235/). *Biomedicines*. [Basic Science / Preclinical]
Filippi K (2026). [PMID: 41965903](https://pubmed.ncbi.nlm.nih.gov/41965903/). *Nat Commun*. [Basic Science / Preclinical]
Serano M (2026). [PMID: 41972723](https://pubmed.ncbi.nlm.nih.gov/41972723/). *Cells*. [Review / Meta-Analysis]
Kora K (2026). [PMID: 40729434](https://pubmed.ncbi.nlm.nih.gov/40729434/). *Brain : a journal of neurology*. [Basic Science / Preclinical]
Atzgerstorfer L (2026). [PMID: 42193934](https://pubmed.ncbi.nlm.nih.gov/42193934/). *Cells*. [Review / Meta-Analysis]
Asanović I (2026). [PMID: 41964657](https://pubmed.ncbi.nlm.nih.gov/41964657/). *Cell Mol Life Sci*. [Review / Meta-Analysis]
Shearer A (2026). [PMID: 41955018](https://pubmed.ncbi.nlm.nih.gov/41955018/). *JCI Insight*. [Basic Science / Preclinical]
Jones FJS (2026). [PMID: 41787240](https://pubmed.ncbi.nlm.nih.gov/41787240/). *European journal of neurology*. [Gene Therapy / Novel Therapeutics]
Jeong SY (2026). [PMID: 41984033](https://pubmed.ncbi.nlm.nih.gov/41984033/). *Am J Physiol Cell Physiol*. [Basic Science / Preclinical]
Ozlu C (2026). [PMID: 42036360](https://pubmed.ncbi.nlm.nih.gov/42036360/). *Muscle Nerve*. [Epidemiology / Natural History]